DANTRIUM

This brand name is authorized in Australia, Canada, Estonia, France, Ireland, Japan, Malta, Netherlands, New Zealand, Romania, United Kingdom, United States, South Africa

Active ingredients

The drug DANTRIUM contains one active pharmaceutical ingredient (API):

1 Dantrolene UNII 287M0347EV - DANTROLENE SODIUM

The receptor molecule for dantrolene has not been identified. Dantrolene inhibits the binding of ryanodine. Under some conditions, dantrolene will lower intra-sarcoplasmic calcium concentrations in the resting state. This may be more important in diseased muscle (e.g. In malignant hyperthermia in humans and swine stress syndrome) than in muscle with normal function. Read about Dantrolene

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
DANTRIUM Capsules	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC
DANTRIUM Powder for solution for injection	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
M03CA01	Dantrolene	M Musculo-skeletal system → M03 Muscle relaxants → M03C Muscle relaxants, directly acting agents → M03CA Dantrolene and derivatives
Discover more medicines within M03CA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 1779P, 1780Q
Country: CA	Health Products and Food Branch	Identifier(s): 01997572, 01997602
Country: EE	Ravimiamet	Identifier(s): 1790333
Country: FR	Base de données publique des médicaments	Identifier(s): 60385682, 65074386, 67807645
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 142199, 161561, 182475, 182476, 185725, 197460, 26174, 26182, 43539
Country: IE	Health Products Regulatory Authority	Identifier(s): 66443, 66451
Country: JP	医薬品医療機器総合機構	Identifier(s): 1229002M1036
Country: MT	Medicines Authority	Identifier(s): AA729/27701, AA729/27702
Country: NL	Z-Index G-Standaard	Identifier(s): 13516132
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 29335, 3204
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 10635, 10636, 2297
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68769001
Country: US	FDA, National Drug Code	Identifier(s): 42023-123, 42023-124, 42023-125
Country: ZA	Health Products Regulatory Authority	Identifier(s): H/17.1/64, H/17.1/65, M/17.1/0253